Key facts
- This page summarizes Alan P. Timmins's Form 4/A - Amendment filing for CytoDyn Inc. (CYDY).
- 6 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 30 Nov 2021, 17:31.
Alan P. Timmins - 24 Nov 2021 Form 4/A - Amendment Insider Report for CytoDyn Inc. (CYDY)
- Reporting relationship
- Director
- Issuer ticker
- CYDY
- Reported as of
- 24 Nov 2021
- Net transaction value
- $0
- SEC form
- 4/A - Amendment
- Accepted by SEC
- 30 Nov 2021, 17:31:50 UTC
- Original report date
- 29 Nov 2021
- Prior SEC filing
- 20 Oct 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Antonio Migliarese, Attorney-In-Fact Signature of Reporting Person
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Alan P. Timmins filed Form 4/A - Amendment for CytoDyn Inc. (CYDY) on 30 Nov 2021.
Change
- Previous filing in this sequence was filed on 20 Oct 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CYDY
transaction
Derivative
Non-qualified Stock Option
Disposed to Issuer
- Transaction value
- Shares
- -36,986
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 24 Nov 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 36,986
- Exercise price
- $1.05
- Footnotes
- F1
CYDY
transaction
Derivative
Non-qualified Stock Option
Award
- Transaction value
- Shares
- +36,986
- Change %
- Price
- Shares after
- 36,986
- Date
- 24 Nov 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 36,986
- Exercise price
- $1.05
- Footnotes
- F1
CYDY
transaction
Derivative
Non-qualified Stock Option
Disposed to Issuer
- Transaction value
- Shares
- -225,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 24 Nov 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 225,000
- Exercise price
- $6.15
- Footnotes
- F1, F2
CYDY
transaction
Derivative
Non-qualified Stock Option
Award
- Transaction value
- Shares
- +225,000
- Change %
- Price
- Shares after
- 225,000
- Date
- 24 Nov 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 225,000
- Exercise price
- $6.15
- Footnotes
- F1, F2
CYDY
transaction
Derivative
Non-qualified Stock Option
Disposed to Issuer
- Transaction value
- Shares
- -225,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 24 Nov 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 225,000
- Exercise price
- $1.39
- Footnotes
- F1
CYDY
transaction
Derivative
Non-qualified Stock Option
Award
- Transaction value
- Shares
- +112,500
- Change %
- Price
- Shares after
- 112,500
- Date
- 24 Nov 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 112,500
- Exercise price
- $1.39
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Alan P. Timmins is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 2 footnotes
Footnote F1
The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the "2012 Plan")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, each outstanding stock option that had been granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on December 1, 2021, with the balance of the unvested portion of such option, if any, immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service.
Footnote F2
56,250 shares vested on August 31, 2020; the balance vested in equal amounts on November 30, 2020, February 28, 2021, and May 31, 2021.